Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RayzeBio, Inc. - Common Stock (NQ: RYZB )

23.89 +0.01 (+0.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 121,837
Open 23.68
Bid (Size) 9.260 (2)
Ask (Size) 24.97 (1)
Prev. Close 23.88
Today's Range 22.71 - 24.48
52wk Range 17.95 - 26.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From Rayzebio, Inc.
Via GlobeNewswire
RayzeBio to Participate in Upcoming Investor Conferences in November 2023
From Rayzebio, Inc.
Via GlobeNewswire

Performance

YTD
-0.46%
-0.46%
1 Month
+18.62%
+18.62%
3 Month
-0.46%
-0.46%
6 Month
-0.46%
-0.46%
1 Year
-0.46%
-0.46%

More News

Read More
RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors
From Rayzebio, Inc.
Via GlobeNewswire
FDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETs
From Rayzebio, Inc.
Via GlobeNewswire
RayzeBio to Present at European Society for Medical Oncology (ESMO) Congress
From Rayzebio, Inc.
Via GlobeNewswire
RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Via Benzinga
Specialty Asian Grocer Maison Solutions Opens For Trading
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From RayzeBio, Inc.
Via Business Wire
SoftBank-Owned Arm Jumps 20% In Market Debut
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.